Tag Archives: inflammation

Sanofi and IGM Biosciences and partner over new class of antibody medicines for the treatment of cancer, immunology, and inflammatory diseases

(PRESS RELEASE) SANOFI, 29-Mar-2022 — /EuropaWire/ — Sanofi (EPA: SAN), a global biopharmaceutical company focused on human health, has announced an exclusive worldwide collaboration agreement signed with IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company focused on creating and … Read the full press release

Cambridge and Oxford researchers discovered new molecule that plays a key role in the immune response that is triggered by influenza infections

Researchers at the University of Cambridge and the University of Oxford have discovered a new molecule that plays a key role in the immune response that is triggered by influenza infections. The molecule, a so-called mini viral RNA, is capable … Read the full press release

University of Exeter: wild orangutans in Borneo treat joint and muscle inflammation with Dracaena cantleyi plant

EXETER, 15-Jan-2018 — /EuropaWire/ — Scientists have discovered that the same plant used by indigenous people on Borneo is also used by wild orangutans to treat joint and muscle inflammation. Borneo Nature Foundation scientists have been observing wild Bornean orangutans in … Read the full press release

Milestone for the diagnosis of inflammatory bowel disease

Clinicians at the University Hospital Erlangen show how a new laser-based imaging technique termed MSOT can detect inflammation more accurately than current non-invasive diagnostic procedures and thereby help reduce the burden to patients MUNICH, 30-Mar-2017 — /EuropaWire/ — Ulcerative colitis … Read the full press release

LMU led researchers defined a previously unknown pathway that triggers inflammation

Using a combination of newly developed methods, researchers led by LMU immunologist Veit Hornung have defined a previously unknown pathway that triggers inflammation. MUNICH, 04-Apr-2016 — /EuropaWire/ — The immune system in vertebrates is capable of distinguishing “self” from “non-self” components, … Read the full press release

SAVOR-TIMI-53 cardiovascular outcomes trial of ONGLYZA® results announced by AstraZeneca and Bristol-Myers Squibb

20-6-2013 — /europawire.eu/ — AstraZeneca and Bristol-Myers Squibb announced today top-line results of the Phase IV SAVOR-TIMI-53 (Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus) clinical trial of Onglyza ® (saxagliptin). In this study of adult patients with … Read the full press release